CompletedPhase 1ACTRN12611000213943

Evaluation of Maastricht Index(MI) between patients receiving a standard enteral feeding product or kitchen made enteral feeding in an Intensive Care Unit(ICU) of a teaching hospital

a double blind randomized clinical trial to evaluate Maastricht Index (MI) between patients receiving a standard enteral feeding product or kitchen made enteral feeding in an ICU of a teaching hospital in Iran


Sponsor

Shahid Beheshti University of Medical Sciences

Enrollment

60 participants

Start Date

Jan 10, 2009

Study Type

Interventional

Conditions

Summary

Maastricht index is an international parameter for assessment of nutritional status in hospitalized patients. This study was designed to compare Maastricht index between patients who received a standard enteral feeding product and kitchen made nutrition in ICU of a teaching hospital. Method: A Randomized Clinical trial was done in ICU of shahid Rajaii hospital in Tehran, Iran. 60 patients under enteral feeding enrolled the study and evaluated for 10 days. Patients were randomized to receive fresubin (a standard enteral feeding available in Iran) or kitchen made nutrition that is routine nutrition delivery in most hospitals of Iran. In both groups nasogastric tubes were used for delivery of nutrients. Assessments of patients on the basis of Maastricht index were done at baseline, third day and seventh day after beginning enteral feeding.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 60 Yearss

Plain Language Summary

Simplified for easier understanding

This study compares standard commercial tube feeding formulas with kitchen-made formulas in ICU patients to see which better supports nutritional status. It is open to adults aged 18 to 60 who are in the ICU and need tube feeding.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

fresubin (a standard enteral feeding available in Iran) 150 cc every 3 hours via enteral feeding tube for 7 days

fresubin (a standard enteral feeding available in Iran) 150 cc every 3 hours via enteral feeding tube for 7 days


Locations(1)

Iran, Islamic Republic Of

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000213943


Related Trials